COVID-19 Response

If approved, molnupiravir would be the first oral antiviral pill for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization.

Johnson & Johnson’s data shows that its COVID-19 booster increased protection to 94% against moderate to severe/critical COVID-19.

Giant’s in-store pharmacies, including those located in Martin’s, are offering Pfizer COVID-19 vaccine boosters to eligible individuals.

If authorized by the Food and Drug Administration, molnupiravir could be the first oral antiviral medicine for COVID-19.

Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions have 21 locations licensed to administer the antibody treatment and serve patients in all 50 states and Puerto Rico.

In addition to administering booster shots to eligible individuals, Kinney pharmacy teams are ready to answer questions, administer other vaccines and fill prescriptions, according to the retailer.

Centers for Disease Control and Prevention director Rochelle Walensky overruled her agency advisory panel by recommending COVID-19 boosters for people at risk of the coronavirus because of their jobs.

The retailer has begun preparations to administer booster shots to those who are eligible, regardless of where they received their original vaccine series.